Financials
Financial year 2025
Worth noting
- Little cash and receivables against the short-term debts.
Revenue
€ 463,597
▼ 18% vs 2024
Profit
Growing€ 16.9 million
▲ 10% vs 2024
Debts
Low€ 226.4 million
▲ 37% vs 2024
Kaneka Europe Holding Company from Zaventem, company number BE0640747653, closed financial year 2025 with a result of € 16.9 million after tax. For that financial year Kaneka Europe Holding Company recorded revenue of € 463,597 and equity of € 207.3 million. Compared with financial year 2024, the result moved from € 15.3 million to € 16.9 million. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 10, 2025.
What happened at Kaneka Europe Holding Company?
What happened at Kaneka Europe Holding Company in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Jean Vandael stepped down as director. NBB
- Olivier Renson stepped down as director. NBB
- Mamoru Kadokura stepped down as director. NBB
- Kan Okabe stepped down as director. NBB
- Keisuke Araki stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 16.9 million (▲ 10% vs 2024). Source: NBB ↗
- Mamoru Kadokura became a director. NBB
- Kazuhiko Fujii stepped down as director. NBB
In short
From € 12.4 million profit in 2022 to € 16.9 million profit in 2025.
Paid € 332,454 in corporate taxes since 2022.
Best year ever: 2025, with € 16.9 million profit.
Paid out € 58.2 million in dividends to the owners in total.
A new publication or filing at Kaneka Europe Holding Company? We notify you, reason included.
Follow Kaneka Europe Holding CompanyNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
The shares are held by Kaneka Corporation (100%). It owns 100% of Kaneka Medical Europe, 100% of Kaneka Eurogentec SA, 90% of Kaneka Belgium NV and 87.2% of AB-Biotics SA itself.
Directors
According to the 2025 annual accounts
since 2023 · until 2028
Kazuhiko Fujii
Director
since 2022 · until 2024
Olivier Renson
Director
since 2023 · until 2028
Mamoru Kadokura
Director
since 2024 · until 2028
since 2022 · until 2028
Keisuke Araki
Director
since 2022 · until 2028
Shareholders
Kaneka Corporation
100%
Participations
Establishments
Establishment units
Physical locations of this company
Lenneke Marelaan 4
1932 Zaventem
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
Details
- Company number
- 0640.747.653
- VAT number
- BE 0640.747.653
- Registered office
- Lenneke Marelaan 4, 1932 Zaventem
- Names & denominations
- Kaneka Europe Holding Company
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 8 October 2015
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Activiteiten van holdings
Speur- en ontwikkelingswerk op biotechnologisch gebied
Holdings
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige zakelijke dienstverlening, neg
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering